Effect of HECNU in malignant supratentorial gliomas--a phase II study (Q44432565)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 1988

Language	Label	Description	Also known as
English	Effect of HECNU in malignant supratentorial gliomas--a phase II study	scientific article published in November 1988

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Effect of HECNU in malignant supratentorial gliomas--a phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Serge Przedborski

2

object named as

S Przedborski

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

P Georges

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

J Brotchi

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M Chatel

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

D Gédouin

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

J Hildebrand

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 November 1988

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

211-219

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/3066853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/3066853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/3066853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma—First evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3066853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-agent chemotherapy of brain tumors. A five-year review

1 reference

https://pubmed.ncbi.nlm.nih.gov/3066853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of primary brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3066853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00163703

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44432565&oldid=2206642969"